Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

COMPLETED NA

Efficacy of Targeted Memory Reactivation for Enhancing Exposure Therapy

NCT04663672 · View on ClinicalTrials.gov ↗

Study Summary

This study evaluates whether a scent applied during exposure therapy and during subsequent sleep will increase the durability of treatment effects for individuals with fear of spiders, contamination, and enclosed spaces.

Interventions

  • OTHER Experimental Scent
  • OTHER Control Scent
  • OTHER No-Scent Control
  • BEHAVIORAL In-Vivo Exposure

Study Locations (1)

Texas

  • Laboratory for the Study of Anxiety Disorders, University of Texas at Austin — Austin

Trial Details

FieldValue
Enrollment Target 158 participants
Start Date 2019-01-29
Est. Completion 2020-03-01
Phase NA

Sponsor

University of Texas at Austin

225 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04663672

The ClinicalTrials.gov registry entry for NCT04663672 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 225 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 3 conditions, with Obsessive-Compulsive Disorder appearing as the primary indexed condition, and to 4 interventions — of which Experimental Scent is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT04663672 reports 1 study location spanning 1 distinct geographic area — top geographies include Texas. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT04663672 about?

NCT04663672 is a clinical study titled "Efficacy of Targeted Memory Reactivation for Enhancing Exposure Therapy". This study evaluates whether a scent applied during exposure therapy and during subsequent sleep will increase the durability of treatment effects for individuals with fear of spiders, contamination, and enclosed spaces.

What is the current status of trial NCT04663672?

This trial is currently completed. It is a NA study. The enrollment target is 158 participants. The study started on 2019-01-29. Estimated completion is 2020-03-01.

What conditions does trial NCT04663672 study?

This clinical trial studies the following conditions: Obsessive-Compulsive Disorder, Claustrophobia, Arachnophobia. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT04663672?

The interventions under investigation include: Experimental Scent (OTHER), Control Scent (OTHER), No-Scent Control (OTHER), In-Vivo Exposure (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT04663672?

This trial is sponsored by University of Texas at Austin, which has 225 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT04663672 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial